Ledger.Open graph →
SEC Form D · Amendment · filed August 2, 2017

Arbor Biotechnologies, Inc

Offering
$15.6M
Sold
$15.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Campbell C. Lewis · Dallas, TXExecShane Albers · Scottsdale, AZDirectorCraig Brazeau · Plainfield, ILDirectorP. R. Morrow, Ii · Dallas, TXDirectorWilliam Abraham · New Brighton, MNDirectorThomas Shapiro · New York, NYDirectorMichael Demane · New Brighton, MNDirectorMichael E. Olshan · Dallas, TXExecThomas Feldstein · New York, NYDirectorTony Borowicz · New Brighton, MNExecRobert Vahradian · New York, NYDirectorAmy Boyle · New York, NYExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗